Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
158,4 USD | -3,56 % | -5,66 % | -11,92 % |
01/05 | Caen los beneficios ajustados y los ingresos de Repligen en el 1T | MT |
01/05 | Transcript : Repligen Corporation, Q1 2024 Earnings Call, May 01, 2024 |
Resumen de negocios
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Filtration
54,4
%
| 496 | 61,9 % | 348 | 54,4 % | -29,87 % |
Chromatography
19,8
%
| 132 | 16,4 % | 127 | 19,8 % | -3,84 % |
Proteins
16,2
%
| 114 | 14,3 % | 103 | 16,2 % | -9,50 % |
Process Analytics
8,9
%
| 54 | 6,7 % | 57 | 8,9 % | +6,18 % |
Other Product
0,6
%
| 6 | 0,7 % | 4 | 0,6 % | -35,76 % |
Royalty and Other
0,1
%
| 0 | 0,0 % | 0 | 0,1 % | +8,50 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
North America
44,0
%
| 345 | 43,0 % | 281 | 44,0 % | -18,45 % |
Europe
37,0
%
| 297 | 37,0 % | 236 | 37,0 % | -20,31 % |
APAC
19,0
%
| 160 | 20,0 % | 121 | 19,0 % | -24,29 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Tony Hunt
CEO | Chief Executive Officer | 60 | 01/05/14 |
Olivier Loeillot
PSD | President | 54 | 02/10/23 |
Jason Garland
DFI | Director of Finance/CFO | 50 | 25/09/23 |
James Bylund
COO | Chief Operating Officer | 61 | 01/03/20 |
Ralf Kuriyel
CTO | Chief Tech/Sci/R&D Officer | 66 | 18/10/16 |
Sondra S. Newman
IRC | Investor Relations Contact | - | - |
Jaime Humara
SAM | Sales & Marketing | - | 01/11/22 |
Kola Otitoju
PRN | Corporate Officer/Principal | - | - |
Christine Gebski
PRN | Corporate Officer/Principal | 56 | 01/01/15 |
Vikas Gupta
PRN | Corporate Officer/Principal | - | 01/03/16 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Karen Dawes
CHM | Chairman | 72 | 01/09/05 |
Director/Board Member | 58 | 12/06/14 | |
Martin Madaus
BRD | Director/Board Member | 64 | 06/02/23 |
Glenn Muir
BRD | Director/Board Member | 65 | 01/10/15 |
Carrie Manner
BRD | Director/Board Member | 50 | 11/06/20 |
Tony Hunt
CEO | Chief Executive Officer | 60 | 01/05/14 |
Director/Board Member | 66 | 26/05/22 | |
Rohin Mhatre
BRD | Director/Board Member | 59 | 01/03/20 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 55 838 548 | 52 159 985 ( 93,41 %) | 0 | 93,41 % |
Información de la empresa
Repligen Corp.
41 Seyon Street Building 1, Suite 100
02453, Waltham
+781 250 0111
http://www.repligen.comEmpresas del grupo
Nombre | Categoría y sector |
---|---|
Repligen Europe BV
Repligen Europe BV Medical DistributorsDistribution Services Part of Repligen Corp., Repligen Europe BV is a Dutch company that wholesales medical and dental instruments. The private company is located in Netherlands. |
Medical Distributors
|
Sector
Ventas por actividad
Ventas por región
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-11,92 % | 8842,59 M | |
-3,43 % | 184 mil M | |
-1,81 % | 107 mil M | |
-4,15 % | 67,52 mil M | |
+1,43 % | 50,06 mil M | |
+11,60 % | 45,67 mil M | |
+3,40 % | 41 mil M | |
+3,03 % | 26,73 mil M | |
+3,21 % | 26,47 mil M | |
+15,23 % | 25,05 mil M |
- Bolsa de valores
- Acciones
- Acción RGEN
- Empresa Repligen Corporation